Tokyo, April 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061212) titled 'Validation of the Reliability and Validity of the Oxford Cognitive Screening-Plus for Patients with Brain Injury' on April 10.
Study Type:
Observational
Primary Sponsor:
Institute - Tokyo Metropolitan University
Condition:
Condition - Patients with Brain injury
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to clarify the reliability and validity of the OCS-Plus in patients with brain injury.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - Patients with a first-time brain injury
Patients capable of maintaining a seated position for 15 minutes or longer
Aged 18 to 89
Patients diagnosed with a brain injury by a physician based on CT or MRI results
Key exclusion criteria - Individuals diagnosed with dementia
Individuals diagnosed with apraxia
Individuals diagnosed with severe aphasia
Individuals diagnosed with severe hemispatial neglect
Target Size - 110
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 04 Month 09 Day
Anticipated trial start date - 2026 Year 04 Month 27 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070041
Disclaimer: Curated by HT Syndication.
